HM Payson & Co. Has $3.32 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

HM Payson & Co. decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 21.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,706 shares of the medical equipment provider's stock after selling 1,876 shares during the quarter. HM Payson & Co.'s holdings in Intuitive Surgical were worth $3,321,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of ISRG. Atala Financial Inc bought a new position in Intuitive Surgical during the 4th quarter worth approximately $25,000. Parvin Asset Management LLC bought a new stake in shares of Intuitive Surgical in the fourth quarter worth $26,000. Global Financial Private Client LLC lifted its position in shares of Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after purchasing an additional 38 shares in the last quarter. Elite Financial Inc. bought a new stake in shares of Intuitive Surgical in the first quarter worth $26,000. Finally, Hurley Capital LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $28,000. Institutional investors own 83.64% of the company's stock.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 216 shares of the company's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president owned 907 shares of the company's stock, valued at $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director directly owned 6,371 shares of the company's stock, valued at $3,312,920. This represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Up 0.6%

Shares of ISRG stock traded up $3.14 on Friday, reaching $543.74. The company had a trading volume of 704,815 shares, compared to its average volume of 1,672,707. The stock has a market capitalization of $194.89 billion, a PE ratio of 85.47, a price-to-earnings-growth ratio of 5.78 and a beta of 1.64. Intuitive Surgical, Inc. has a one year low of $413.82 and a one year high of $616.00. The business's 50-day moving average is $537.11 and its 200 day moving average is $536.76.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same quarter in the prior year, the business earned $1.50 earnings per share. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft downgraded shares of Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their target price for the stock from $515.00 to $440.00 in a report on Monday, June 9th. Royal Bank Of Canada lowered their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Barclays lowered their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. Finally, Citigroup reiterated a "buy" rating and issued a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $588.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.